Home / Markets / News / This pharma stk gained 152% in 1 mth on getting license to manufacture HCQ

This pharma stk gained 152% in 1 mth on getting license to manufacture HCQ

Morepen Laboratories was locked in upper circuit for the third straight trading day, up 10% at Rs 19.43 on the BSE.

stocks, stock market, m arket, sensex, growth, revenue, earnings, results, Q2,Q1, Q3, Q4, COMPANY, nse, bse,

Premium

India is taking a lead in supplying HCQ to the rest of the world, including USA.

2 min read Last Updated : Apr 23 2020 | 11:25 AM IST

Shares of Morepen Laboratories were locked in upper circuit for the third straight trading day, up 10 per cent at Rs 19.43 on the BSE on Thursday as the company has received license to manufacture Hydroxychloroquine (HCQ). HCQ is a drug usually used to treat malaria patients but is also being found useful in treatment of coronavirus (COVID-19) patients.

The stock has rallied 33 per cent in the past three trading days, zooming 152 per cent in the past one month. It had closed at a multi-year low of Rs 7.71 on March 23, 2020. The stock touched a

Topics : Morepen Laboratories Buzzing stocks Markets Sensex Nifty

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in